BREIL GL10 Manual do Utilizador descarregar pdf (Página 27)

E 15.01.2003

F 12.06.1995 JP 16929295

K PRANLUKAST ENTHALTENDE

GRANULA, VERFAHREN ZUR

HERSTELLUNG DER GRANULA UND

VERFAHREN ZUR VERMINDERUNG

DES ZUSAMMENBACKENS VON

PRANLUKAST

O ONO PHARMACEUTICAL CO., LTD.

1-5, Doshomachi 2-chome

Chuo-ku Osaka 541 (JP)

N SASATANI, Seiei, Minase Res. Inst.,

Ono Pharma Co.

1-1, Sakurai 3-chome,

Shimamoto-cho

Mishima-gun, Osaka 618 (JP)

SHIOTA, Masashi, Minase Res. Inst.,

ONO Pharma Co.

1-1, Sakurai 3-chome,

Shimamoto-cho

Mishima-gun, Osaka 618 (JP)

II, Yoshinori, Minase Res. Inst., ONO

Pharma Co.

1-1, Sakurai 3-chome,

Shimamoto-cho

Mishima-gun, Osaka 618 (JP)

Q PCT/JP 19/96001 (Ja)

R WO 19/96041 () 27.12.1996

I A61K031/41, A 61 K 031/44,

A61K031/47, A 61 P 009/10,

A61P035/00, A 61 P 037/00

A 00 883 401

B 97903313.1

C 18.02.1997 Q En

H 16.12.1998 R En

E 02.01.2003

F 29.02.1996 CH 52296

K AT1 REZEPTOR ANTAGONIST ZUR

ANREGUNG VON APOPTOSIS

O Novartis AG

Lichtstrasse 35

4056 Basel (CH)

N DE GASPARO, Marc

Es Planches 123a

CH-2842 Rossemaison (CH)

BULLOCK, Gillian, Rosemary

Innere Margarethenstrasse 17

CH-4051 Basel (CH)

CRISCIONE, Leoluca

Kirchstrasse 15

CH-4313 Möhlin (CH)

Q PCT/EP 19/97000 (En)

R WO 19/97031 () 4.9.1997

I A 61 K 031/41 Z C 07 D 261/12

A 00 934 286

I A 61 K 031/41 Z C 07 D 213/06

A 00 974 584

I A 61 K 031/415 Z C 07 D 233/84

A 00 560 177

I A61K031/415, A 61 K 031/00,

A61P025/14

A 00 851 756

B 96929991.6

C 16.09.1996 Q En

H 08.07.1998 R En

E 15.01.2003

F 18.09.1995 GB 9519021

18.09.1995 GB 9519029

K DIE VERWENDUNG VON

ONDANSETRON ZUR HERSTELLUNG

EINES MEDIKAMENTES ZUR

BEHANDLUNG VON TREMOR

O GLAXO GROUP LIMITED

Glaxo Wellcome House, Berkeley

Avenue

Greenford, Middlesex UB6 0NN (GB)

N RICE, George, Peter, Arthur

11 Denali Terrace

London, Ontario N5X 3W2 (CA)

Q PCT/CA 19/96000 (En)

R WO 19/97010 () 27.3.1997

I A 61 K 031/415 Z A 61 K 031/44

A 00 946 175

I A 61 K 031/415 Z C 07 D 213/06

A 00 974 584

I A 61 K 031/415 Z A 61 K 031/475

A 01 052 993

I A 61 K 031/4178 Z C 07 D 401/04

A 01 169 317

I A 61 K 031/4196 Z C 07 D 249/14

A 01 044 970

I A 61 K 031/42 Z C 07 D 311/94

A 00 787 723

I A 61 K 031/425 Z C 07 D 311/94

A 00 787 723

I A 61 K 031/425 Z C 07 D 277/34

A 00 801 063

I A 61 K 031/425 Z C 07 D 277/46

A 00 934 938

I A 61 K 031/425 Z C 07 D 277/84

A 00 988 296

I A 61 K 031/426 Z C 07 D 277/24

A 01 090 914

I A61K031/435, A 61 K 031/44,

A61K031/445, C 07 D 211/10,

C07D211/70, C 07 D 401/04,

C07D405/14

A 00 659 078

B 93920438.4

C 31.08.1993 Q En

H 28.06.1995 R En

E 15.01.2003

F 31.08.1992 US 938427

K ANABASEIN DERIVATE ZUR

BEHANDLUNG VON

DEGENERATIVEN ERKRANKUNGEN

DES NERVENSYSTEMS

O UNIVERSITY OF FLORIDA

RESEARCH FOUNDATION, INC.

223 Grinter Hall

Gainesville, FL 32611 (US)

N KEM, William, R.

837 NW 51st Terrace

Gainesville, FL 32605 (US)

ZOLTEWICZ, John, A.

2330 NW 38th Street

Gainesville, FL 32605 (US)

MEYER, Edwin, M.

1130 NW 52nd Terrace

Gainesville, FL 32605 (US)

Prokai-Tatrai, Dr. Katalin Department

of Chemistry

PB 100497,University of Florida

Gainesville, FL 32611 (US)

Q PCT/US 19/93008 (En)

R WO 19/94005 () 17.3.1994

I A61K031/435, A 61 P 001/08

A 00 689 437

B 94911178.5

C 15.03.1994 Q En

H 03.01.1996 R En

E 08.01.2003

F 18.03.1993 GB 9305593

K VERWENDUNG VON GRANISETRON

ZUR BEHANDLUNG VON

POSTOPERATIVER ÜBELKEIT UND

ERBRECHEN

O F.HOFFMANN-LA ROCHE AG

Grenzacherstrasse 124

4070 Basel (CH)

N SANGER, Gareth John, SmithKline

Beecham Pharmac.

Coldharbour Road, The Pinnacles

Harlow, Essex CM19 5AD (GB)

DAVEY, Philip Timothy, SmithKline

Beecham Pharmac.

Coldharbour Road, The Pinnacles

Harlow, Essex CM19 5AD (GB)

DOTT, Christopher Stuart

31 Furzefield Crescent

Reigate, Surrey RH2 7HQ (GB)

Q PCT/EP 19/94000 (En)

R WO 19/94021 () 29.9.1994

I A 61 K 031/435 Z C 07 D 221/10

A 00 863 878

I A 61 K 031/435 Z C 07 D 217/22

A 01 077 945

I A 61 K 031/435 Z C 07 D 495/14

A 01 087 977

I A 61 K 031/435 Z C 07 D 401/14

A 01 121 356

I A 61 K 031/4355 Z C 07 D 471/14

A 01 092 717

I A 61 K 031/4365 Z A 61 K 009/19

A 01 105 102

I A 61 K 031/4375 Z C 07 D 471/04

A 01 155 017

I A61K031/44, C 07 D 473/10,

C07D473/08, C 07 D 473/06,

C07D473/04, A 61 P 037/00

A 00 584 347

B 93908327.5

C 01.03.1993 Q En

H 02.03.1994 R En

E 15.01.2003

F 04.03.1992 US 846354

07.08.1992 US 926665

K ENANTIOMERE HYDROXYLIERTE

XANTHINVERBINDUNGEN

O CELL THERAPEUTICS, INC.

201 Elliott Avenue West, Suite 400

Seattle, WA 98119 (US)

N BIANCO, James A.

2349 Fauntleroy Avenue SW, Unit

301

Seattle, WA 98126 (US)

WOODSON, Paul

9218 NE 142nd Court

Bothell, WA 98011 (US)

PORUBEK, David

8723 238th Street SW, Unit C-11

Edmonds, WA 98026 (US)

SINGER, Jack

3515 East Spring Street

Seattle, WA 98112 (US)

Q PCT/US 19/93002 (En)

R WO 19/93017 () 16.9.1993

I A 61 K 031/44 Z C 07 D 213/55

A 00 630 366

I A 61 K 031/44 Z C 07 D 213/65

A 00 649 412

I A 61 K 031/44 Z A 61 K 031/435

A 00 659 078

I A 61 K 031/44 Z C 07 D 311/94

A 00 787 723

I A 61 K 031/44 Z C 07 D 207/09

A 00 869 118

I A 61 K 031/44 Z A 61 K 031/41

A 00 883 401

I A61K031/44, A 61 K 031/415,

A61P011/02

A 00 946 175

B 97945135.8

C 01.10.1997 Q En

H 06.10.1999 R En

15.1.2003 +pat+ 1

1 2 ... 22 23 24 25 26 27 28 29 30 31 32 ... 185 186

Comentários a estes Manuais

Sem comentários

BREIL GL10 Manual do Utilizador Página 27

Comentários a estes Manuais